<code id='90AB4DD9C5'></code><style id='90AB4DD9C5'></style>
    • <acronym id='90AB4DD9C5'></acronym>
      <center id='90AB4DD9C5'><center id='90AB4DD9C5'><tfoot id='90AB4DD9C5'></tfoot></center><abbr id='90AB4DD9C5'><dir id='90AB4DD9C5'><tfoot id='90AB4DD9C5'></tfoot><noframes id='90AB4DD9C5'>

    • <optgroup id='90AB4DD9C5'><strike id='90AB4DD9C5'><sup id='90AB4DD9C5'></sup></strike><code id='90AB4DD9C5'></code></optgroup>
        1. <b id='90AB4DD9C5'><label id='90AB4DD9C5'><select id='90AB4DD9C5'><dt id='90AB4DD9C5'><span id='90AB4DD9C5'></span></dt></select></label></b><u id='90AB4DD9C5'></u>
          <i id='90AB4DD9C5'><strike id='90AB4DD9C5'><tt id='90AB4DD9C5'><pre id='90AB4DD9C5'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:65
          Stock illustration of computer and medication
          Adobe

          Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

          PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

          advertisement

          “My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Novo: Oral version of Ozempic leads to 15% weight loss
          Novo: Oral version of Ozempic leads to 15% weight loss

          LISELOTTESABROE/AFP/GettyImagesAnoralversionofsemaglutide,thedrugmarketedasOzempicandWegovy,ledtodra

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Studies point to risks of excluding people with obesity from drug trials

          AdobePeoplewithobesityoftengounderrepresentedindrugdevelopmenttrials,acriticalgapthatresearcherssayl